Skip to main content
Clinical Trials/CTRI/2023/03/050240
CTRI/2023/03/050240Not yet recruitingPhase 3

Varenicline and mobile behavioral assistance for tobacco cessation in HIV care in India - NA

ational Cancer Institute0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •HIV positive
  • •willing to participate in the study

Exclusion Criteria

  • •1.Past 30-day use of tobacco cessation pharmacotherapy or behavioral treatments
  • •2.Pregnant or planning to become pregnant in the next 6 months
  • •3.Breastfeeding
  • •4.Myocardial infarction in past 30 days or unstable angina
  • •5.History of liver or kidney failure
  • •6.ALT and AST > 2 times ULN or creatinine clearance <50 in past 6 months
  • •7.History of suicide attempt
  • •8.Current suicidal ideation53
  • •9.Untreated or unstable major depressive disorder
  • •10.History of psychosis or on anti-psychotic medications
  • •11.Cognitive impairment limiting ability to consent
  • •12.Allergy to varenicline

Investigators

Sponsor
ational Cancer Institute

Similar Trials